CD55-DEFICIENT PROTEIN-LOSING ENTEROPATHY
Clinical trials for CD55-DEFICIENT PROTEIN-LOSING ENTEROPATHY explained in plain language.
Never miss a new study
Get alerted when new CD55-DEFICIENT PROTEIN-LOSING ENTEROPATHY trials appear
Sign up with your email to follow new studies for CD55-DEFICIENT PROTEIN-LOSING ENTEROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug offered to patients with rare gut disorder
Disease control APPROVED_FOR_MARKETINGThis trial gives people with CD55-deficient protein-losing enteropathy access to an experimental drug called pozelimab. The condition causes the gut to leak proteins, leading to serious health problems. The goal is to control the disease and improve symptoms.
Matched conditions: CD55-DEFICIENT PROTEIN-LOSING ENTEROPATHY
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:46 UTC
-
Lifesaving drug now available for kids with rare gut disease
Disease control APPROVED_FOR_MARKETINGThis program provides access to an experimental drug called pozelimab for people with CHAPLE disease, a rare and life-threatening immune disorder that causes protein loss from the gut. The goal is to offer treatment and track long-term safety. Participants must have a confirmed g…
Matched conditions: CD55-DEFICIENT PROTEIN-LOSING ENTEROPATHY
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:43 UTC